協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/04 | 2,297 | 2,318 | 2,264 | 2,269 | -40 | -1.7% | 825,700 |
2018/12/03 | 2,354 | 2,362 | 2,307 | 2,309 | -18 | -0.8% | 839,300 |
2018/11/30 | 2,297 | 2,329 | 2,278 | 2,327 | +61 | +2.7% | 1,864,000 |
2018/11/29 | 2,276 | 2,301 | 2,262 | 2,266 | +10 | +0.4% | 913,500 |
2018/11/28 | 2,312 | 2,350 | 2,249 | 2,256 | -25 | -1.1% | 955,400 |
2018/11/27 | 2,295 | 2,297 | 2,257 | 2,281 | +20 | +0.9% | 800,000 |
2018/11/26 | 2,237 | 2,265 | 2,222 | 2,261 | -2 | -0.1% | 657,700 |
2018/11/22 | 2,240 | 2,269 | 2,239 | 2,263 | +33 | +1.5% | 560,100 |
2018/11/21 | 2,207 | 2,238 | 2,185 | 2,230 | -14 | -0.6% | 705,500 |
2018/11/20 | 2,260 | 2,264 | 2,216 | 2,244 | -18 | -0.8% | 890,000 |
2018/11/19 | 2,261 | 2,273 | 2,229 | 2,262 | -11 | -0.5% | 780,100 |
2018/11/16 | 2,260 | 2,295 | 2,249 | 2,273 | +57 | +2.6% | 1,077,400 |
2018/11/15 | 2,192 | 2,234 | 2,182 | 2,216 | +6 | +0.3% | 1,092,100 |
2018/11/14 | 2,239 | 2,239 | 2,198 | 2,210 | -29 | -1.3% | 1,296,600 |
2018/11/13 | 2,213 | 2,244 | 2,192 | 2,239 | -23 | -1% | 774,800 |
2018/11/12 | 2,247 | 2,273 | 2,233 | 2,262 | -7 | -0.3% | 666,400 |
2018/11/09 | 2,279 | 2,287 | 2,259 | 2,269 | +4 | +0.2% | 711,900 |
2018/11/08 | 2,270 | 2,276 | 2,247 | 2,265 | +30 | +1.3% | 895,300 |
2018/11/07 | 2,206 | 2,258 | 2,204 | 2,235 | +32 | +1.5% | 1,394,200 |
2018/11/06 | 2,229 | 2,235 | 2,187 | 2,203 | +16 | +0.7% | 941,300 |
2018/11/05 | 2,172 | 2,196 | 2,158 | 2,187 | -4 | -0.2% | 1,021,600 |
2018/11/02 | 2,229 | 2,234 | 2,142 | 2,191 | -17 | -0.8% | 1,705,200 |
2018/11/01 | 2,198 | 2,261 | 2,182 | 2,208 | +13 | +0.6% | 1,885,300 |
2018/10/31 | 2,150 | 2,210 | 2,104 | 2,195 | +204 | +10.2% | 2,109,600 |
2018/10/30 | 1,986 | 2,014 | 1,972 | 1,991 | +17 | +0.9% | 1,071,800 |
2018/10/29 | 1,958 | 1,999 | 1,944 | 1,974 | +48 | +2.5% | 1,074,300 |
2018/10/26 | 1,951 | 1,969 | 1,918 | 1,926 | -28 | -1.4% | 1,132,200 |
2018/10/25 | 1,995 | 2,002 | 1,937 | 1,954 | -87 | -4.3% | 1,727,200 |
2018/10/24 | 2,039 | 2,069 | 2,035 | 2,041 | +33 | +1.6% | 1,218,500 |
2018/10/23 | 2,031 | 2,037 | 2,005 | 2,008 | -45 | -2.2% | 1,146,800 |
2018/10/22 | 2,036 | 2,065 | 2,025 | 2,053 | +2 | +0.1% | 576,700 |
2018/10/19 | 2,054 | 2,074 | 2,027 | 2,051 | -17 | -0.8% | 1,089,900 |
2018/10/18 | 2,056 | 2,086 | 2,049 | 2,068 | +18 | +0.9% | 617,200 |
2018/10/17 | 2,020 | 2,054 | 2,012 | 2,050 | +43 | +2.1% | 1,002,500 |
2018/10/16 | 1,997 | 2,012 | 1,993 | 2,007 | +10 | +0.5% | 933,900 |
2018/10/15 | 1,993 | 2,015 | 1,990 | 1,997 | -14 | -0.7% | 872,900 |
2018/10/12 | 1,982 | 2,022 | 1,980 | 2,011 | +5 | +0.2% | 1,583,600 |
2018/10/11 | 2,017 | 2,037 | 1,981 | 2,006 | -54 | -2.6% | 1,501,400 |
2018/10/10 | 2,106 | 2,106 | 2,043 | 2,060 | -36 | -1.7% | 800,300 |
2018/10/09 | 2,080 | 2,110 | 2,075 | 2,096 | +24 | +1.2% | 1,794,300 |
2018/10/05 | 2,031 | 2,081 | 2,027 | 2,072 | +26 | +1.3% | 1,248,900 |
2018/10/04 | 2,109 | 2,112 | 2,041 | 2,046 | -48 | -2.3% | 1,198,600 |
2018/10/03 | 2,092 | 2,105 | 2,072 | 2,094 | -15 | -0.7% | 1,126,000 |
2018/10/02 | 2,133 | 2,160 | 2,105 | 2,109 | -8 | -0.4% | 1,742,100 |
2018/10/01 | 2,140 | 2,146 | 2,112 | 2,117 | -12 | -0.6% | 868,900 |
2018/09/28 | 2,140 | 2,165 | 2,114 | 2,129 | +35 | +1.7% | 1,530,300 |
2018/09/27 | 2,139 | 2,146 | 2,091 | 2,094 | -48 | -2.2% | 1,224,200 |
2018/09/26 | 2,099 | 2,144 | 2,094 | 2,142 | +53 | +2.5% | 1,087,400 |
2018/09/25 | 2,112 | 2,119 | 2,073 | 2,089 | +5 | +0.2% | 1,111,300 |
2018/09/21 | 2,104 | 2,107 | 2,066 | 2,084 | -11 | -0.5% | 1,551,200 |
1451~
1500
件表示中 / 3581件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 257,000円 | +11.3% | -5.4% | 2.26% | 19.78倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 214,000円 | +5.7% | +3.9% | 2.68% | 10.65倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 502,900円 | +1.7% | -2.9% | 3.18% | 32.99倍 | 1.73倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 181,500円 | -3.5% | -50.2% | 4.41% | 14.70倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 274,400円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム